Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT05638711
NCT05638711CompletedNot Applicable

Built-in Calculator Optimizes Continuous Veno-venous Hemofiltration Prescription and Improves Therapeutic Quality in Critically-ill Acute Kidney Injury Patients

Taipei Medical University1 site in 1 country1 target enrollmentStarted: January 1, 2019Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
1
Locations
1
Primary Endpoint
Mortality
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The goal of this observational study is to compare in ICU patients received CVVH treatment. The main questions it aims to answer are:

Control of Filtration fraction by built-in calculator

  • Reduced filter clotting and prolong filter lifespan
  • Improve patient mortality Participants will divided into before group and after group based on the day when built-in calculator for calculating Filtration fraction was utilized.

Researchers will compare before group to see if there were differences in clotting events, filter downtime, filter lifespan, mortality, etc.

Detailed Description

built-in calculator for calculating Filtration fraction

  • The calculator was built in prescription system since 2020/10/01
  • providing tempt filtration fraction for operators to adjust CVVH dose
  • the protocol of patient care didn't change between before and after group.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
20 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •ICU patients received CVVH during 2019~2021 (3 years) in our hospital

Exclusion Criteria

  • •under age of 20, pregnant, or with HIV infection

Outcomes

Primary Outcomes

Mortality

Time Frame: 30 days, 60 days, "through study completion, an average of 1.5 year" mortality in ICU and in Hospital

Patient death

Secondary Outcomes

  • electrolytes_2(the last record received before CVVH (in an average of 1 hour), the first record received CVVH after 24 hours, the first record received after CVVH (in an average of 1 hour))
  • electrolytes_4(the last record received before CVVH (in an average of 1 hour), the first record received CVVH after 24 hours, the first record received after CVVH (in an average of 1 hour))
  • acid-base balance_2(the last record received before CVVH (in an average of 1 hour before CVVH treatment), the first record received CVVH after 24 hours (in an average of 1 hour after CVVH treatment), the first record received after CVVH (in an average of 1 hour after CVVH))
  • Filter downtime("through the complete treatment course hours, an average of 24 hours")
  • electrolytes_1(the last record received before CVVH (in an average of 1 hour), the first record received CVVH after 24 hours, the first record received after CVVH (in an average of 1 hour))
  • Filter clotting events("through the complete treatment course hours, an average of 24 hours")
  • Filter lifespan("through the complete treatment course hours, an average of 24 hours")
  • acid-base balance_1(the last record received before CVVH (in an average of 1 hour before CVVH treatment), the first record received CVVH after 24 hours (in an average of 1 hour after CVVH treatment), the first record received after CVVH (in an average of 1 hour after CVVH))
  • others_2(the last record received before CVVH (in an average of 1 hour before CVVH treatment), the first record received CVVH after 24 hours (in an average of 1 hour after CVVH treatment), the first record received after CVVH (in an average of 1 hour after CVVH))
  • electrolytes_3(the last record received before CVVH (in an average of 1 hour), the first record received CVVH after 24 hours, the first record received after CVVH (in an average of 1 hour))
  • others_1(the last record received before CVVH (in an average of 1 hour before CVVH treatment), the first record received CVVH after 24 hours (in an average of 1 hour after CVVH treatment), the first record received after CVVH (in an average of 1 hour after CVVH))

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Recruiting
Not Applicable
The Efficiency of the Central Venous Catheter Care ProtocolStem Cell Transplant ComplicationsCentral Venous Catheter Exit Site Infection
NCT05705895Saglik Bilimleri Universitesi Gulhane Tip Fakultesi60
Completed
Not Applicable
Simulation for Continuous Veno-venous Hemofiltration in Intensive caReHemofiltrationNurse TrainingHealth Care Provider Education
NCT02379234University Hospital, Angers85
Unknown
Not Applicable
Pressure Volume LoopDecompensated Heart FailureCardiogenic Shock
NCT04478188Cedars-Sinai Medical Center150
Completed
Not Applicable
Comparison of Volume Controlled Ventilation With 1:1 Inspiratory to Expiratory Ratio and Autoflow-volume Controlled Ventilation in Robot-assisted Laparoscopic Radical Prostatectomy With Steep Trendelenburg Position and PneumoperitoneumRobot Assisted Laparoscopic Prostatectomy
NCT03202953Yonsei University78
Terminated
Not Applicable
National Inferior Vena Cava (IVC) Filter RegistryVenous Thrombo-embolism
NCT01367184American Venous Forum20,000